NYU Lung Cancer Biomarker Center
Brief description of study
The NYU Lung Cancer Biomarker Center's goals are to identify and validate biomarkers for the early detection of lung cancer, to develop and follow a large cohort at risk for lung and other cancers, and to identify preneoplastic cellular changes and lesions. We will facilitate the clinical validation and application of biomarkers through our own investigations and through participation in multi-institutional Early Detection Research Network (EDRN) studies.
Clinical Study Identifier: 8896
ClinicalTrials.gov Identifier: NCT8896
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.
